View Cart (0 items)

Pharmaceutical

Teva’s MS Drug Misses Study Goal

Teva Pharmaceutical Industries Ltd. said its experimental drug laquinimod, an oral treatment for multiple sclerosis, did not reduce patients'' annual relapse rate in a late-stage clinical trial, Forbes reported. Shares
Read More